Mergers & Acquisitions ·
Aspire Biopharma Holdings completed its acquisition of Dura Driver Control Systems (DCS) for approximately $30 million…
ASBPWAspire-Lakewood Holdings, Inc.
Aspire Biopharma Holdings completed its acquisition of Dura Driver Control Systems (DCS) for approximately $30 million in cash and entered into a $22.5 million senior secured revolving credit facility to fund the transaction. The company also issued convertible promissory notes with an aggregate principal amount of $3,750,000 for a purchase price of $3,000,000, reflecting a 20% original issue discount, to provide working capital. DCS generated approximately $209.5 million in revenue and $22.3 million in Adjusted EBITDA for the twelve months ended December 31, 2025. Aspire Biopharma Holdings operates in the biotechnology industry, developing patent-pending sublingual drug delivery technologies.